Abstract:Objective To evaluate the efficacy and safety of different courses of luliconazole 1％ cream in the treatment of tinea pedis.Methods A randomized,double-blind,multicenter controlled trial was conducted.According to a stratified randomization protocol,420 patients positive for fungal elements on direct microscopy were equally and randomly divided into 3 groups:short-term group applying luliconazole 1％ cream once daily for 2 weeks followed by placebo once daily for the next 2 weeks,long-term group applying luliconazole 1％ cream once daily for 4 weeks,bifonazole group applying bifonazole 1％ cream once daily for 4 weeks.Efficacy was assessed in terms of mycological clearance and clinical response rates on week 2,3,4 and 6 after initiation of treatment.Statistical analysis was carried out by paired t test,analysis of variance,chi-square test and a nonparametric test.Results Finally,398 patients were eligible for the efficacy analysis.The clinical response rate in the bifonazole group,shortterm group and long-term group was 29.29％,31.43％ and 35.00％ respectively on week 2 after initiation of treatment (P ＞ 0.05),73.57％,78.57％ and 70.00％ respectively on week 3 (P ＞ 0.05),89.29％,91.43％ and 89.29％ respectively on week 4 (P ＞ 0.05),with the mycological clearance rate being 49.29％,58.57％ and 57.86％ respectively on week 2 (P ＞ 0.05),80.00％,87.86％ and 85.00％ respectively on week 4 (P ＞ 0.05).Significant differences were observed on week 2 after the end of treatment in mycological clearance rate (80.71％ in the bifonazole group vs.90.00％ in the short-term group vs.89.29％ in the long-term group,P ＜ 0.05),but not in clinical response rate (92.14％ in the bifonazole group vs.92.86％ in the short-term group vs.92.14％ in the longterm group,P ＞ 0.05).The incidence rate of local adverse reactions was 0.71％ in the bifonazole group,0 in the short-term group and 2.14％ in the long-term group.Conclusion Luliconazole 1％ cream is effective and well tolerated in the treatment of tinea pedis,with the efficacy of 2-week once-daily regimen equivalent to that of 4-week once-daily regimen.

Bifonazole -Co Cream in the Treatment of Tinea Cruris and Tinea Corporis:A Randomized Double-blind Vehicle-controlled Clinical Trial

Double-blind Randomized Controlled Clinical Trial of Butenafine Hydrochloride 1% Cream in the Treatment of Tinea Corporis and Cruris and Tinea Pedis

Randomized, Investigator-Masked, Controlled, Multicenter Clinical Trial of 0.25% Amorolfine Hydrochloride Cream in the Treatment of Tinea Corporis and Cruris and Tinea Pedis

Clinical effect observation of itraconazole capsule combined with bifona-zole cream in the treatment of tinea cruris

A randomized, double-blind, controlled study with luliconazle cream (1％) versus terbinafine cream (1％) in patients with tinea cruris

Terbinafine versus itraconazole for treatment of dermatophyte onychomycosis: a meta-analysis

Evaluation of efficacy and safety of 1％ luliconazole cream in the treatment of tinea corporis and tinea cruris

Multicenter, Double-Blind, Randomized Controlled Sdudy on Sertaconazole 2% Cream and Miconazole 2% Cream in the Treatment of Tinea Pedis and Tinea Corporis and Cruris

Evaluation of Efficacy and Safety of 2 % Sertaconazole Nitrate Cream in the Treatment of Tinea Corporis & Cruris and Tinea Pedis

The Curative Effect Observation of Sertaconazole Nitrate Cream in the Treatment of Tinea Cruris

Evaluation of efficacy and safety of flutrimazole cream 1% in the treatment of tinea pedis

Treatment of Superficial Mycosis with Compound Bifonazole Solution: A Double-blind Controlled Clinical Trial

Comparative Study of Topical Terbinafine 1% Cream versus Butenafine 1% Cream in the Treatment of Tinea Cruris

Comparison of 2 Weeks Versus 4 Weeks of Luliconazole 1％ Cream for the Treatment of Tinea Pedis: a Randomized, Double-Blind, Multicenter, Controlled Trial

Short-term Oral Terbinafine Combined with Topical Bifonazole Cream Treating Moderate and Severe Tinea Pedis

Comparative efficacy of 1% terbinafine hydrochloride cream and 1% ciclopirox olamine cream alone and in combination for the treatment of dermatophytosis

Experience of using the 1,5% Tetranyl U cream in patients with tinea corporis and tinea cruris

Observation of clinical efficacy of sporanox combined with bifonazole cream in treatment of tinea pedis

Evaluation of efficacy and safety of 1% luliconazole cream in the treatment of tinea pedis

Efficacy of terbinafine and itraconazole in different doses and in combination in the treatment of tinea infection: A randomized controlled parallel group open labeled trial with clinico-mycological correlation

Comparison of 1-Week Terbinafime Hydrochloride Cream, 1- and 4-Week Miconazole Nitrate Cream in the Treatment of Interdigital Tinea Pedis: a Multi-Center, Randomized and Double-Blind Study